Manufacturers Should Provide Episode-Of-Care Data To MCOs - Tufts Plan
Executive Summary
Pharmaceutical companies should provide episode-of- care data to managed care organizations, Tufts Health Plan Chief Medical Officer Philip Boulter, MD, said May 22.
You may also be interested in...
Humana Adding Fourth Tier To Drug List; Fewer Drugs Need Prior Authorization
Humana is replacing its three-tier drug formulary with a four-tier pharmacy benefit design.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials